Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Thermogenesis stock

Learn how to easily invest in Thermogenesis stock.

Thermogenesis is a medical devices business based in the US. Thermogenesis shares (THMO) are listed on the NASDAQ and all prices are listed in US Dollars. Thermogenesis employs 39 staff and has a trailing 12-month revenue of around $10.2 million.

How to buy Thermogenesis stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – THMO. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience

Robinhood


  • Commission-free trading
  • Commission-free crypto
  • No minimum account balance

Promoted

tastyworks


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Thermogenesis stock price (NASDAQ: THMO)

Use our graph to track the performance of THMO stocks over time.

Thermogenesis shares at a glance

Information last updated 2023-01-19.
Latest market close$5.08
52-week range$2.67 - $45.00
50-day moving average $4.41
200-day moving average $11.57
Wall St. target price$45.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.91

Buy Thermogenesis stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Thermogenesis stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Thermogenesis price performance over time

Historical closes compared with the close of $5.08 from 2023-01-25

1 week (2023-01-19) 43.50%
1 month (2022-12-27) 78.25%
3 months (2022-10-27) 4,980.00%
6 months (2022-07-27) 2,440.00%
1 year (2022-01-27) 497.65%
2 years (2021-01-27) 88.85%
3 years (2020-01-27) 5.33
5 years (2018-01-26) 72.21%

Thermogenesis financials

Revenue TTM $10.2 million
Gross profit TTM $3.5 million
Return on assets TTM -17.47%
Return on equity TTM -213.24%
Profit margin -102.6%
Book value $7.33
Market capitalisation $3.5 million

TTM: trailing 12 months

Thermogenesis share dividends

We're not expecting Thermogenesis to pay a dividend over the next 12 months.

Have Thermogenesis's shares ever split?

Thermogenesis's shares were split on a 1:45 basis on 21 December 2022. So if you had owned 45 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Thermogenesis shares – just the quantity. However, indirectly, the new 4400% higher share price could have impacted the market appetite for Thermogenesis shares which in turn could have impacted Thermogenesis's share price.

Thermogenesis share price volatility

Over the last 12 months, Thermogenesis's shares have ranged in value from as little as $2.67 up to $45. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Thermogenesis's is 2.5368. This would suggest that Thermogenesis's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Thermogenesis overview

ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company manufactures and markets AXP II Automated Cell Separation System, an automated cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing, and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. It offers PXP Point-of-Care System, an automated sterile system for the automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; PXP-LAVARE System, an automated system designed to wash, re-suspend, and volume reduce cell suspensions; PXP-1000 System, an automated system for fast and reproducible separation of multiple cellular components from blood with minimal red blood cell contamination; and X-Series products, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, X-Mini for small scale cell purification, and X-BACS System under development for large scale cell purification. It also provides CAR-TXpress Platform that addresses the critical unmet need for large scale cellular processing and chemistry, manufacturing, and controls needs. The company was formerly known as Cesca Therapeutics Inc.

Frequently asked questions

What percentage of Thermogenesis is owned by insiders or institutions?
Currently 26.316% of Thermogenesis shares are held by insiders and 1.327% by institutions.
How many people work for Thermogenesis?
Latest data suggests 39 work at Thermogenesis.
When does the fiscal year end for Thermogenesis?
Thermogenesis's fiscal year ends in December.
Where is Thermogenesis based?
Thermogenesis's address is: 2711 Citrus Road, Rancho Cordova, CA, United States, 95742
What is Thermogenesis's ISIN number?
Thermogenesis's international securities identification number is: US88362L1008
What is Thermogenesis's CUSIP number?
Thermogenesis's Committee on Uniform Securities Identification Procedures number is: 883623209

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site